COVID19 Vaccine Candidate By Seattle Research Lab

A potential coronavirus vaccine has been greenlighted for clinical trials. The candidate aims to deliver the same efficacy as Pfizer's shots, but without the subzero cold storage requirement. As we've all observed the past few months, when it comes to the choice of a COVID-19 vaccine, there are factors to consider aside from efficacy.HDT Bio, a biotech startup based in Seattle, has just announced that their COVID-19 vaccine candidate has been approved for clinical trials in India.

Christopher Pirie HDT Bio

Previous press releases

This CBT Expert In NYC Uses Mindfulness And Hypnot

Rising Florida Social Media Influencer Facing Charges

Get The Best Dental Implant Cosmetic Dentistry Aff

Get The Best Commercial Insurance For Your Airbnb

DC Witter Group Economic Recovery Relies on Vaccine Rollout

Ideanomics Completes the Acquisition of Cash

The Best Fractional CMO For Customer Acquisition S

ten24 Announces the Formation of New Business

3 Current Trends of Store Interior Designing In India

Tips about Mobile App Development Budget and Maintenance Cost

Important Facts about Solar Junction Box

Rate for General Contractors in Orlando


Select The Right Manufacturer and Buy The Best PC Water Cooling

StoneFly Introduces Backup and DR Solution for Remote Offices and SMBs

Indian Tea is now available in Florida Orlando

The Internationally Acclaimed JoJo Allrich Show Airs on Youtube

Get Your Medication Delivered To Your Home In Calg

SandB Pallets Provides Custom Build Wooden Pallets Option